Why Is TransMedics Stock Trading Higher Today? - TransMedics Gr (NASDAQ:TMDX)
TransMedics jumps with 159% YoY Q4 2023 revenue surge to $81.2 million. Analysts upbeat on strategic growth, price target raised to $105.
Stay updated with breaking news from Brain Death. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TransMedics jumps with 159% YoY Q4 2023 revenue surge to $81.2 million. Analysts upbeat on strategic growth, price target raised to $105.
Recalled death experiences, a form of consciousness after cardiac arrest, are on the rise. How are they measured and what are the implications for cardiac arrest care?
Jeremy Medina was accidentally hit in the head with a bat at baseball practice and subsequently rendered comatose on a ventilator to help him breathe.
New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
The transition from life to death is not as binary as it seems. Research is uncovering previously unknown and poorly understood complexities about the dying process.